Hiatal hernia and drugs of ingredients of ibrutinib - a phase IV clinical study of FDA data
Hiatal hernia is found among people who take drugs with ingredients of ibrutinib, especially for people who are female, 60+ old , have been taking the drugs for 1 - 2 years. This phase IV clinical study is created by eHealthMe based on reports of 60,903 people who have side effects when taking drugs with ingredients of ibrutinib from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Ibrutinib, Imbruvica.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
60,903 people reported to have side effects when taking drugs with ingredients of ibrutinib.
Among them, 78 people (0.13%) have Hiatal hernia
What is Hiatal hernia?
Hiatal hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm) is found to be associated with 2,424 drugs and 1,489 conditions by eHealthMe.
Number of reports submitted per year:
Time on drugs with ingredients of ibrutinib when people have Hiatal hernia *:
- < 1 month: 25.0 %
- 1 - 6 months: 25.0 %
- 6 - 12 months: 8.33 %
- 1 - 2 years: 33.33 %
- 2 - 5 years: 8.33 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Hiatal hernia when taking drugs with ingredients of ibrutinib *:
- female: 58.44 %
- male: 41.56 %
Age of people who have Hiatal hernia when taking drugs with ingredients of ibrutinib *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 2 %
- 60+: 98 %
Conditions people have *:
- Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 48 people, 61.54%
- Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 16 people, 20.51%
- Pain: 8 people, 10.26%
- High Blood Pressure: 5 people, 6.41%
- Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 5 people, 6.41%
- Cardiac Disorder: 4 people, 5.13%
- Nausea (feeling of having an urge to vomit): 4 people, 5.13%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 3.85%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 3.85%
- Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 3 people, 3.85%
Other drugs people take *:
- Pantoprazole: 9 people, 11.54%
- Vitamin D3: 8 people, 10.26%
- Plavix: 8 people, 10.26%
- Eliquis: 8 people, 10.26%
- Rituxan: 7 people, 8.97%
- Magnesium: 7 people, 8.97%
- Protonix: 7 people, 8.97%
- Baby Aspirin: 7 people, 8.97%
- Tylenol: 7 people, 8.97%
- Vitamin D: 6 people, 7.69%
Other side effects people have besides Hiatal hernia *:
- Fatigue (feeling of tiredness): 28 people, 35.90%
- Nausea (feeling of having an urge to vomit): 21 people, 26.92%
- Joint Pain: 18 people, 23.08%
- Indigestion: 16 people, 20.51%
- Dizziness: 15 people, 19.23%
- High Blood Pressure: 15 people, 19.23%
- Pain: 15 people, 19.23%
- Headache (pain in head): 14 people, 17.95%
- Rashes (redness): 14 people, 17.95%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 17.95%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drugs with ingredients of ibrutinib, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on ibrutinib. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pravachol and Amidate drug interaction - now
- Lanirapid and Thrombocytopenia - now
- Aleve and Glioblastoma - 3 seconds ago
- Cyanocobalamin and Dementia - 3 seconds ago
- Cardiac Failure Congestive and Septic Shock - 5 seconds ago
- Allopurinol and Pneumonia Pseudomonal - 5 seconds ago
- Allopurinol and Gingival Bleeding - 6 seconds ago
- Aleve and Pneumonia Legionella - 6 seconds ago
- Aldactone and Campylobacter Gastroenteritis - 8 seconds ago
- Alupent and Neck Pain - 10 seconds ago